Author:
Patel Hetal,Marley Stephen B.,Gordon Myrtle Y.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference5 articles.
1. Copland M, Hamilton A, Elrick LJ, et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood2006; 107:4532–4539.
2. Maxwell SA, Kurzrock R, Parsons SJ, et al. Analysis of p210BCR-ABL tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukaemia patients. Cancer Res1987; 47:1731–1739.
3. Patel H, Marley SB, Gordon MY. Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL and GRB2. Genes Chromosomes Cancer2006; 45:1121–1129.
4. Schleuning M, Mittermuller J, Kolb HJ. Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patients. Eur J Haematol1999; 62:149–154.
5. Guo JQ, Wang JYJ, Arlinghaus RB. Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukaemia patients. Cancer Res1991; 51:3048–3051.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献